Our final molecule, a scFv-extended IgG fusion of a particular composition and geometry, causes additional MOA components beyond receptor trapping: HER2 is being actively internalized and degraded and hence tumor cells are deprived of their most potent oncogenic signaling powerhouse. Here, ERBB2 is linked to neoplasm.